Evidence map›Paper›PMID 24645851›Full record

ArticleBMC gastroenterology2014

A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing!

Hazel Duncan, Elaine Buchanan, Tracey Cardigan, Vikki Garrick, Lee Curtis, Paraic McGrogan, Andrew Barclay, Richard K Russell

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effect of ModulenWorld journal of gastroenterology · 2025
    Trial
  4. Review
  5. Article
  6. Revolution in diet therapy for inflammatory bowel disease.JGH open : an open access journal of gastroenterology and hepatology · 2024
    Review
  7. Review
  8. Dietary interventions in Crohn's disease: A simple solution to refractory disease.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Diet and nutrition in the management of inflammatory bowel disease.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2021
    Review
  14. Review
  15. How Can a Polymeric Formula Induce Remission in Crohn's Disease Patients?International journal of molecular sciences · 2021
    Review
  16. Review
  17. Review
  18. Observational
  19. ORAL AND ENTERAL NUTRITION THERAPY IN INFLAMMATORY BOWEL DISEASES AMONG THE PEDIATRIC POPULATION: A LITERATURE REVIEW.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2020
    Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hazel DuncanDepartment of Nutrition & Dietetics, Yorkhill Hospital Glasgow, Dalnair Street, Glasgow G3 8SJ, United Kingdom. hazel.duncan4@nhs.net.
Elaine Buchanan
Tracey Cardigan
Vikki Garrick
Lee Curtis
Paraic McGrogan
Andrew Barclay
Richard K Russell
Stobhill Hospital · GB

Funding

CIHR G0800675Medical Research Council G0800675MRF_ C0482
6 · The paper itself

Abstract

backgroundA limited body of research suggests that ongoing maintenance enteral nutrition (MEN) can be beneficial in maintaining disease remission in Crohn's Disease (CD). We aimed to assess how achievable MEN is and whether it helps to prolong remission.

methodsPatients newly diagnosed with CD in 2010 and 2011 who commenced exclusive enteral nutrition (EEN) for 8 weeks were followed up for a year post diagnosis. All patients who took EEN were encouraged to continue MEN post EEN. Data on azathioprine use was also collected. Categorical variables were compared using chi-square/Fischer's exact test. Medians were expressed along with complete data ranges.

results59 patients (34 male, median age 11.07 years, range 2.5-16.33 years) were identified. 11/59 (18%) had a poor response to EEN and were switched to steroids. 48/59 patients completed 8 weeks EEN and achieved clinical remission/response. 46/48 patients received Modulen IBD®, 29/48 (60%) consumed EEN orally and 19/48 (40%) via NGT. 15/48 (31%) patients were able to continue MEN post EEN completion. MEN was consumed for a mean of 10.8 months (range 4-14 months). 14/15 patients drank MEN and 1/15 had MEN via NGT. Remission rates at 1 year in patients continuing MEN were 60% (9/15) compared to 15% (2/13) in patients taking no treatment (p = 0.001) and 65% (13/20) in patients taking azathioprine (p = 0.14).

conclusionA sub group of patients can continue MEN as a maintenance treatment and this seems a useful strategy, especially in those who are not commencing azathioprine.

Indexed as

AdolescentAdrenal Cortex HormonesAzathioprineChildChild, PreschoolCohort StudiesCrohn DiseaseEnteral NutritionFemaleHumansImmunosuppressive AgentsMaleRemission InductionRetrospective StudiesTertiary Care CentersTreatment OutcomeAdrenal Cortex HormonesAzathioprineImmunosuppressive Agents

Identifiers

PMID24645851
PMCPMC4234202
OpenAlexW2079315433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.